Amendments and Clarifications Sample Clauses

The Amendments and Clarifications clause establishes the procedures for modifying or interpreting the terms of an agreement after it has been executed. Typically, this clause requires that any changes or clarifications to the contract be made in writing and agreed upon by all parties involved, ensuring that informal or verbal modifications are not legally binding. Its core function is to maintain the integrity and clarity of the contract by preventing misunderstandings or disputes over unauthorized or ambiguous changes.
Amendments and Clarifications. The Project Company and ▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇▇ Agusta ▇▇▇▇▇▇▇ wish to make the amendments reflected in Schedule C. As consideration for the changes reflected herein Project Company shall pay Assignee the consideration set forth in Schedule D.
Amendments and Clarifications. The Parties hereby acknowledge and agree that (a) ▇▇▇▇▇ agrees to be bound by the terms and conditions of the Confidentiality Agreement as if it were originally a party thereto; (b) the term of the Confidentiality Agreement is amended such that it shall not terminate until the later of (i) five (5) years after the termination of the business relationship between the parties to the Confidentiality Agreement on its original terms or (ii) ten (10) years following the Term (as defined in the License Agreement); (c) the terms of this Agreement and the transactions contemplated hereunder, and any information exchanged hereunder shall be deemed “Confidential Information” for purposes of the Confidentiality Agreement and any use or disclosure thereof shall be governed by this Agreement; (d) (i) ▇▇▇▇ shall have the right to disclose the Confidential Information of ▇▇▇▇▇ relating to Finished Product to the extent reasonably necessary for ▇▇▇▇ to fulfill its obligations hereunder, and (ii) ▇▇▇▇▇ shall have the right to disclose Confidential Information of ▇▇▇▇ relating to the ANDAs or Finished Product to the extent reasonably necessary for ▇▇▇▇▇ to exercise its rights under Section 11.3, including Schedule 11.3, or 12.3; in each case (x) notwithstanding the last sentence of paragraph 1 of the Confidentiality Agreement and (y) provided that ▇▇▇▇ or ▇▇▇▇▇, as the case may be, has obtained appropriate undertakings of confidentiality from the recipient of such Confidential Information and shall be liable for any breach by such recipient of such undertakings; and (e) the legal department of each Party shall be permitted to retain one copy of the other Party’s Confidential Information solely for archival purposes, notwithstanding paragraph 5 of the Confidentiality Agreement. Each Party acknowledges that any and all other information provided to it by the other Party or its representatives concerning such other Party and its Affiliates shall remain subject to the terms and conditions of the Confidentiality Agreement after the date hereof and the Effective Date.
Amendments and Clarifications. The parties agree upon ▇▇▇▇▇ amendments and clarifications, as follows: 4.3.1. On the subject of Annex 1: • It is hereby clarified that for the purpose of Annex 1, the Hospital is designated as “Buyer”. • Amendment to clause 1.3 of Annex 1. Clause shall be replace by the following: Orders as per clause 1.4 hereunder are accepted and Novartis Gene Therapies Products are supplied only on condition that the Buyer is validly authorised to administer the Novartis Gene Therapies Product, or cause the Novartis Gene Therapies Product to be administered. In this sense, in order to allow Novartis Gene Therapies to comply with its obligations as holder of a wholesale dealer license, or a manufacturer’s license, or as distributor and supplier of medicinal products to statutory or public health authorities (e.g. in Ireland, the Health Service Executive (‘HSE’)) or to others, or to comply with its obligations as employer of employees who provide services and support to customers of Novartis Gene Therapies, or to comply with the requirements of applicable law, the Seller shall, on its own costs and with 5 days in-advance written notification, and only in serious and well-grounded cases, have the right to audit whether the Buyer complies with the provisions of this Agreement. The Buyer shall provide the Seller with necessary cooperation and allow access to relevant materials and documents or Products in accordance with applicable laws. The Seller may appoint third person to perform the audit. The Buyer shall accept the appointment and shall provide the third person with the same cooperation as the Seller shall be entitled to under this Agreement, provided the third party shall be committed by the Seller to confidentiality with regard to Confidential Information of both Parties. In case the audit reveals the breach of this Agreement by the Buyer, the Seller is entitled to compensation of costs of the audit. • Amendment to clause 1.8 of Annex 1: The place of delivery of the Product to the Hospital (DAP) will be hospital pharmacy of FN Motol, Department of cytostatic central preparation and this will be stated on each Order Form (Annex 3). • It is hereby clarified that section 2.1, sixth sentence of Annex 1 is to be understood as follows: “the Buyer shall bear the entire risk of damage or loss as from the moment of delivery at the place of destination DAP”. • Amendment to clause 2.1 of Annex 1: The sentence “Without prejudice to this, Novartis Gene Therapies reserves the rig...
Amendments and Clarifications. 1.01 Article II “Definitions,” Section 2.01 of the Agreement shall hereafter read as follows:
Amendments and Clarifications. The provisions of this MOA may require future modifications. Accordingly, at the request of either EM or RW, the parties shall negotiate and, to the extent mutually agreed, amend this agreement as necessary or proper to reflect their respective interest, or to reflect changing statutory or legislative direction or to accommodate new DOE SNF or HLW processing technologies/methods.
Amendments and Clarifications. The Amended Agreement is amended and/or clarified (as applicable) in the manner set out in the Schedule to this letter on and from the date on which this letter is signed by both parties as set out below.
Amendments and Clarifications. 2.1 The Parties agree that if any judicial or regulatory authority of competent jurisdiction determines (or has determined) that BA is not required to furnish any service or item or provide any benefit to telecommunications carriers otherwise required to be furnished or provided to Community hereunder, then BA may, at its sole option, avail itself of any such determination by providing written notice thereof to Community. 2.2 Notwithstanding anything to the contrary contained in this Agreement, the Parties agree that BA shall only be required to provide Combinations and any services related to its provision of Combinations to the extent (a) required by Applicable Law or (b) mutually agreed to by the Parties in writing after the date hereof. 2.3 For the avoidance of doubt, the Parties acknowledge and agree that the term "Dedicated Transport", as described in Part II, Section 2.9.5.2 of Appendix 1 hereto, does not include within its definition transmissions between locations that include subscriber premises. 2.4 The reciprocal compensation provisions set forth in this Agreement do not apply to Internet-bound traffic because such traffic is not local traffic. 2.5 The entry into, filing and performance by BA of this Agreement does not in any way constitute a waiver by BA of any of the rights and remedies it may have to seek review of any of the provisions of the Separate Agreement, or to petition the Department, other administrative body or court for reconsideration or reversal of any determination made by any of them, or to seek review in any way of any portion of this Agreement in connection with Community's election under Section 252(i) of the Act.

Related to Amendments and Clarifications

  • Amendments and Changes The Contracting Parties may make amendments and changes to this Agreement by mutual consent Such amendments and changes shall be made in the form of additional protocols which, upon entry into force in the manner prescribed in Article 15, shall constitute an integral and inseparable part of this Agreement

  • Amendments and Modifications Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

  • Amendments and Supplements The Company shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective and in compliance with the provisions of the Securities Act until all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such securities have been withdrawn.

  • Amendments and Variations No amendment to or Variation of this Agreement shall be effective unless made in writing by duly authorized representatives of both Parties, if not provided otherwise herein. The Agreement can be amended in compliance with the provisions of Article 61 of the Public Procurement Law of the Republic of Latvia.

  • Amendments and Modification This Agreement may not be modified, amended, altered or supplemented except upon the execution and delivery of a written agreement executed by the parties hereto.